Watson will lead Red Queen Bio's government affairs strategy and deepen the company's engagement with key stakeholders across the federal government, national laboratories and agencies including the Department of War, Department of Energy and Department of Health and Human Services.
"Ian has spent his career operating at the intersection of frontier biotechnology, national security and public health," said Nikolai Eroshenko, co-founder and CEO of Red Queen Bio. "The biosecurity landscape is evolving faster than many traditional systems were designed to respond. Red Queen Bio is building for that reality, and Ian understands what it takes to deploy and scale new technological capabilities."
Watson has decades of experience spanning biodefense, biotechnology policy, pandemic preparedness and chemical, biological, radiological and nuclear defense.
Most recently, he served as Deputy Assistant Secretary of War for Chemical, Biological, Radiological, and Nuclear Defense, overseeing the development of chemical and biological defense capabilities for the Joint Force. He also served as Executive Secretary of the Biodefense Executive Council and led the Department of War's Biosurveillance Program.
Before that, he was Deputy Assistant Secretary and Director of the Office of Strategy, Policy, Planning, and Requirements within the Administration for Strategic Preparedness and Response at the Department of Health and Human Services, where his responsibilities included industrial base expansion, supply-chain management and the Defense Production Act program during the COVID-19 response.
From 2018 to 2020, Watson was Assistant Director for Biotechnology and Biosecurity at the White House Office of Science and Technology Policy, where he led the National Bioeconomy Initiative with the National Security Council, co-chaired National Science and Technology Council biodefense and biological sciences subcommittees, and helped shape federal policy around the bioeconomy and biological security.
Earlier in his career, Watson held a series of leadership roles at the Defense Threat Reduction Agency, including overseeing international biological threat reduction programs. He began his career in missile defense and arms control, including work on the Army's PAC-3 and MEADS programs.
"What drew me to Red Queen Bio is the ambition of the mission, and the amazing team they have assembled," said Watson. "The biological threat landscape has consistently been described for more than a decade as rapidly accelerating, and there is an argument to be made that it has done so in advance of our collective ability to adequately detect, understand and respond with the cohesion and timeliness necessary. Red Queen Bio is confronting the problem with the technical depth and urgency of a technology company, while staying focused on the national security realities."
About Red Queen Bio
Red Queen Bio PBC is an AI biosecurity company building next-generation technologies to help governments and communities respond to emerging biological threats. Founded by Nikolai Eroshenko and Hannu Rajaniemi, the company brings together advances in biology and artificial intelligence to create faster, more adaptive approaches to biosecurity and preparedness. Red Queen Bio is headquartered in Boston and is backed by OpenAI, Cerberus Ventures and others. For more information, please visit www.redqueen.bio.
Media Contact
[email protected]
SOURCE Red Queen Bio
Share this article